Pediatrix Medical Group, Inc. (NYSE:MD) Receives Average Rating of "Moderate Buy" from Analysts

Key Points

• Pediatrix Medical Group has received an average rating of "Moderate Buy" from analysts, with five hold recommendations, two buy recommendations, and one strong buy recommendation.
• The company's stock price target has an average estimate of $16.79, following recent adjustments by various research firms.
• Pediatrix reported earnings of $0.53 per share for the last quarter, exceeding estimates, although its quarterly revenue declined by 7.1% compared to the previous year.

Shares of Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report) have earned an average recommendation of "Moderate Buy" from the eight brokerages that are presently covering the stock, Marketbeat Ratings reports. Five analysts have rated the stock with a hold recommendation, two have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $16.7857.

Several research firms have weighed in on MD. Zacks Research upgraded shares of Pediatrix Medical Group to a "strong-buy" rating in a research report on Monday, August 11th. Wall Street Zen cut shares of Pediatrix Medical Group from a "strong-buy" rating to a "buy" rating in a research report on Saturday, September 13th. Leerink Partners lifted their price target on shares of Pediatrix Medical Group from $14.50 to $17.00 and gave the stock a "market perform" rating in a research report on Friday, September 5th. Finally, UBS Group lifted their price target on shares of Pediatrix Medical Group from $16.00 to $16.50 and gave the stock a "neutral" rating in a research report on Thursday, August 14th.

Pediatrix Medical Group Trading Up 0.5%

MD opened at $17.09 on Friday. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 0.70. The stock has a market capitalization of $1.49 billion, a PE ratio of 13.25 and a beta of 1.26. Pediatrix Medical Group has a 1-year low of $11.59 and a 1-year high of $17.67. The firm has a 50-day moving average price of $15.72 and a two-hundred day moving average price of $14.38.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.53 earnings per share for the quarter, beating the consensus estimate of $0.42 by $0.11. The firm had revenue of $468.84 million during the quarter, compared to analysts' expectations of $464.37 million. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The company's quarterly revenue was down 7.1% compared to the same quarter last year. During the same quarter last year, the company posted $0.34 EPS. As a group, equities analysts anticipate that Pediatrix Medical Group will post 1.38 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Pediatrix Medical Group

Institutional investors have recently modified their holdings of the business. California State Teachers Retirement System boosted its position in shares of Pediatrix Medical Group by 0.9% in the fourth quarter. California State Teachers Retirement System now owns 80,327 shares of the company's stock valued at $1,054,000 after acquiring an additional 752 shares during the period. AlphaQuest LLC boosted its position in shares of Pediatrix Medical Group by 16.0% in the first quarter. AlphaQuest LLC now owns 5,877 shares of the company's stock valued at $85,000 after acquiring an additional 811 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management boosted its position in shares of Pediatrix Medical Group by 8.7% in the second quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 11,913 shares of the company's stock valued at $171,000 after acquiring an additional 950 shares during the period. SummerHaven Investment Management LLC boosted its position in shares of Pediatrix Medical Group by 0.9% in the first quarter. SummerHaven Investment Management LLC now owns 112,327 shares of the company's stock valued at $1,628,000 after acquiring an additional 1,028 shares during the period. Finally, New York State Common Retirement Fund boosted its position in shares of Pediatrix Medical Group by 1.7% in the second quarter. New York State Common Retirement Fund now owns 62,245 shares of the company's stock valued at $893,000 after acquiring an additional 1,034 shares during the period. Institutional investors and hedge funds own 97.71% of the company's stock.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.